The beautiful Fall is here and it's time for pumpkins and creative Halloween costumes. For The Aesthetic Society, this has been the year of reimagination and we've continued to reinvent both our internal and external processes to set ourselves up for
success in the new aesthetic landscape.
The study analyzes public interest in the off-label use of glucagon-like peptide 1 (GLP-1) agonists, particularly Ozempic, for cosmetic weight loss through Google Trends data.